Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a CMS plan for changes in drug coverage that brought a wave of criticism; a government task force recommended more people at risk for HIV take pre-exposure prophylaxis, known as PrEP; the American College of Cardiology issued an Expert Consensus Pathway on treatment of patients with type 2 diabetes and atherosclerotic cardiovascular disease.

Read more about the stories in this podcast:

CMS Aims at Drug Prices Through Part D, MA Step Therapy, Pharmacy Rebates: https://www.ajmc.com/newsroom/cms-aims-at-drug-prices-through-part-d-ma-step-therapy-pharmacy-rebates

CMS Finalizes New Structure to Move Home Health to Value-Based Payment: https://www.ajmc.com/newsroom/cms-finalizes-new-structure-to-move-home-health-to-valuebased-payment

USPSTF Recommends Clinicians Prescribe HIV PrEP to All High-Risk Patients: https://www.ajmc.com/newsroom/uspstf-recommends-clinicians-prescribe-hiv-prep-to-all-highrisk-patients

ACC Pathway Finds Empagliflozin "Preferred" SGLT2 Therapy for Patients With Type 2 Diabetes, ASCVD: https://www.ajmc.com/newsroom/acc-pathway-finds-empagliflozin-preferred-sglt2-therapy-for-patients-with-type-2-diabetes-ascvd

American Society of Hematology Annual Meeting & Exposition: https://www.ajmc.com/conferences/ash-2018

Twitter: @EBOncology: https://twitter.com/eboncology